Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | CFTR | P13569 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | MYC | P01106 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.47 |
| ▸ | DHFR | P00374 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3511612 | 0.89 | LMNA (0.59) | LMNATSHRNR4A2ALDH1A1CFTR | |
| SCHEMBL30341822 | 0.86 | KMT2A (0.55) | LMNATSHRNR4A2ALDH1A1CFTR | |
| SCHEMBL6113326 | 0.85 | MEN1 (0.50) | LMNATSHRALDH1A1HSD17B10POLB | |
| SCHEMBL32667968 | 0.85 | MEN1 (0.50) | LMNATSHRALDH1A1HSD17B10POLB | |
| SCHEMBL126498 | 0.85 | MEN1 (0.50) | LMNATSHRALDH1A1HSD17B10POLB | |
| SCHEMBL27301503 | 0.84 | MEN1 (0.47) | LMNATSHRNR4A2ALDH1A1HSD17B10 | |
| SCHEMBL2898209 | 0.83 | MYC (0.54) | LMNATSHRNR4A2ALDH1A1CFTR | |
| SCHEMBL9157077 | 0.83 | KMT2A (0.49) | LMNATSHRALDH1A1HSD17B10POLB | |
| SCHEMBL29634134 | 0.83 | TSHR (0.53) | LMNATSHRALDH1A1CFTRHSD17B10 | |
| SCHEMBL19849652 | 0.83 | TSHR (0.53) | LMNATSHRALDH1A1CFTRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118240886-A | Method for synthesizing ethyl salicylate compound by biological enzyme catalysis | 济南大学 | 2024-06-25 | — | — | CN | claimed |
| CN-102791695-B | Cyclopentyl-and cycloheptylpyrazoles as FXR modulators | 霍夫曼-拉罗奇有限公司 | 2016-08-24 | — | — | CN | claimed |
| JP-2008500943-A | — | — | 2008-01-17 | — | — | JP | claimed |
| EP-1622717-A2 | AFFINITY-BASED ENRICHMENT OF PHOSPHORYLATED PEPTIDES AND/OR PROTEINS | ProteoSys AG (DE) | 2006-02-08 | — | — | EP | claimed |
| WO-2004099233-A2 | AFFINITY-BASED ENRICHMENT OF PHOSPHORYLATED PEPTIDES AND/OR PROTEINS | PROTEOSYS AG (DE) | 2004-11-18 | — | — | WO | claimed |
| EP-4700024-A1 | CYCLOPENTYLPYRAZOLAMINE DERIVATIVE AND USE THEREOF | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2026-02-25 | — | — | EP | disclosed |
| US-20240383884-A1 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | CORVUS PHARMACEUTICALS, INC. | 2024-11-21 | — | — | US | disclosed |
| WO-2024217431-A1 | CYCLOPENTYLPYRAZOLAMINE DERIVATIVE AND USE THEREOF | 正大天晴药业集团股份有限公司 | 2024-10-24 | — | — | WO | disclosed |
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | MONTE ROSA THERAPEUTICS AG (CH) | 2024-07-04 | — | — | US | disclosed |
| CN-118240886-A | Method for synthesizing ethyl salicylate compound by biological enzyme catalysis | 济南大学 | 2024-06-25 | — | — | CN | disclosed |
| CN-117510360-B | Continuous preparation method, device and product of 2-amino-5-chloro- (N, 3) -dimethylbenzamide | 天津凯莱英医药科技发展有限公司 | 2024-04-12 | — | — | CN | disclosed |
| US-11897874-B2 | Compounds and methods for modulating Interleukin-2-inducible T-cell kinase | CORVUS PHARMACEUTICALS, INC. (US) | 2024-02-13 | — | — | US | disclosed |
| US-20050288340-A1 | Substituted heteroaryl- and phenylsulfamoyl compounds | PFIZER INC | 2005-12-29 | — | — | US | disclosed |
| WO-2004099233-A2 | AFFINITY-BASED ENRICHMENT OF PHOSPHORYLATED PEPTIDES AND/OR PROTEINS | PROTEOSYS AG (DE) | 2004-11-18 | — | — | WO | disclosed |
| US-20030225091-A1 | Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein | BRISTOL-MYERS SQUIBB COMPANY | 2003-12-04 | — | — | US | disclosed |
| US-5026856-A | Bactericides | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1991-06-25 | — | — | US | disclosed |
| EP-0343560-A2 | Isoindoline derivative | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1989-11-29 | — | — | EP | disclosed |
| US-4699698-A | Preparation of benzoic acid ortho-esters and novel compounds of this type | BASF AKTIENGESELLSCHAFT (DE) | 1987-10-13 | — | — | US | disclosed |
| US-4355173-A | Process for the preparation of alkyl carboxylate | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1982-10-19 | — | — | US | disclosed |
| US-3983159-A | Process for producing biphenylpolycarboxylic acid ester | TEIJIN LIMITED (JA) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050288340-A1 | Substituted heteroaryl- and phenylsulfamoyl compounds | PPARA, PPARG, PPARD | LMNA 319/4885TSHR 400/4885NR4A2 54/4885 |
| US-20030225091-A1 | Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein | FABP4, FABP2, FABP1 | LMNA 2337/4885TSHR 2835/4885NR4A2 341/4885 |
| US-20240216355-A1 | PHARMACEUTICAL COMPOSITIONS FOR USE IN THE PREVENTION AND TREATMENT OF A DISEASE OR DISORDER CAUSED BY OR ASSOCIATED WITH ONE OR MORE PREMATURE TERMINATION CODONS | UPF1, NSUN2, RTF2 | LMNA 395/4885TSHR 1410/4885NR4A2 2656/4885 |
| US-20240383884-A1 | COMPOUNDS AND METHODS FOR MODULATING INTERLEUKIN-2-INDUCIBLE T-CELL KINASE | IL2, NFATC1, IL2RA | LMNA 4243/4885TSHR 4016/4885NR4A2 1862/4885 |
| US-11897874-B2 | Compounds and methods for modulating Interleukin-2-inducible T-cell kinase | IL2, NFATC1, IL2RA | LMNA 4243/4885TSHR 4016/4885NR4A2 1862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.